Ubs Asset Management Americas Inc Cellectis S.A. Transaction History
Ubs Asset Management Americas Inc
- $345 Billion
- Q2 2024
A detailed history of Ubs Asset Management Americas Inc transactions in Cellectis S.A. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 1,438,255 shares of CLLS stock, worth $3.24 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,438,255Holding current value
$3.24 Million% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CLLS
# of Institutions
32Shares Held
11.2MCall Options Held
2.8KPut Options Held
17.9K-
Long Focus Capital Management, LLC San Juan, PR4.62MShares$10.4 Million0.35% of portfolio
-
Capital International Investors Los Angeles, CA1.85MShares$4.16 Million0.0% of portfolio
-
Credit Suisse Ag Zurich, V81.44MShares$3.24 Million0.0% of portfolio
-
Baillie Gifford & CO708KShares$1.59 Million0.0% of portfolio
-
Principal Financial Group Inc Des Moines, IA437KShares$983,2500.0% of portfolio
About Cellectis S.A.
- Ticker CLLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,510,800
- Market Cap $102M
- Description
- Cellectis S.A., a clinical stage biotechnological company, develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells. It operates through two segments, Therapeutics and Plants. The company is developing UCART19, an allogeneic T-cell product candidate for the treatm...